Brain CB₂ Receptors: Implications for Neuropsychiatric Disorders

By Roche Michelle   Finn David P  

Pharmaceuticals, Vol. 3, Iss. 8, 2010-08 ,pp. : 2517-2553

MDPI

Access to resources Recommend Favorite

Proteomic and Microscopic Strategies towards the Analysis of the Cytoskeletal Networks in Major Neuropsychiatric Disorders

By Coumans Joëlle V. F.   Palanisamy Suresh K. A.   McFarlane Jim   Moens Pierre D. J.  

International Journal of Molecular Sciences, Vol. 17, Iss. 4, 2016-04 ,pp. : 581-581

MDPI

Access to resources Recommend Favorite

Measurement of Neuropsychiatric Symptoms in Clinical Trials Targeting Alzheimer’s Disease and Related Disorders

By David Renaud   Mulin Emmanuel   Mallea Patrick   Robert Philippe H.  

Pharmaceuticals, Vol. 3, Iss. 8, 2010-07 ,pp. : 2387-2397

MDPI

Access to resources Recommend Favorite

Selective Serotonin Reuptake Inhibitors for Treating Neurocognitive and Neuropsychiatric Disorders Following Traumatic Brain Injury: An Evaluation of Current Evidence

By Yue John K.   Burke John F.   Upadhyayula Pavan S.   Winkler Ethan A.   Deng Hansen   Robinson Caitlin K.   Pirracchio Romain   Suen Catherine G.   Sharma Sourabh   Ferguson Adam R.   Ngwenya Laura B.   Stein Murray B.   Manley Geoffrey T.   Tarapore Phiroz E.  

Brain Sciences, Vol. 7, Iss. 8, 2017-07 ,pp. : 93-93

MDPI

Access to resources Recommend Favorite

Autoantibodies in movement and psychiatric disorders: updated concepts in detection methods, pathogenicity, and CNS entry

By  

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol. 1351, Iss. 1, 2015-09 ,pp. : 22-38

John Wiley & Sons Inc

Access to resources Recommend Favorite